Where does Neurohabilitation Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Neurohabilitation Corporation ranks #10,703 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Neurohabilitation Corporation hold?

Neurohabilitation Corporation holds 29 US utility patents granted between 2015 and 2018, spanning 5 technology areas.

What is Neurohabilitation Corporation's Innovation Score?

Neurohabilitation Corporation has an Innovation Score of 28.5 out of 100 (28th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Neurohabilitation Corporation focus on?

Neurohabilitation Corporation's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 13 patents, ranking #276 of 1,943 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Neurohabilitation Corporation's patent grant rate increasing or decreasing?

Neurohabilitation Corporation's recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Neurohabilitation Corporation's patents?

Neurohabilitation Corporation's patents average 14.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Neurohabilitation Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Neurohabilitation Corporation

USPTO PatentsView assignee record - 29 granted patents across 5 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neurohabilitation ranks #10,703 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 5 technology areas.

#10,703
of 49,997 US assignees by volume: 28th percentile
by Innovation Score (28.5/100): 14.8
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10703 · US Corporation #10,703 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 29 grants
UPPER-Q #10,703/49,997
PHOTO-FINISH National Yunlin…
CPC-NARROW A61N · 5 areas
INNOV-THIN 28.5/100
CLAIMS-RICH 14.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: National Yunlin University of Science and Technology (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neurohabilitation’s 28.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.7 pts (41%) Velocity 0.0 pts (0%) Breadth 7.9 pts (28%) Claim depth 8.9 pts (31%)

Qualcomm Incorporated · highest

85
Kankakee Spikeball · near

29
Millennial Media · near

29
SK hynix system ic · near

29
Neurohabilitation · this assignee

29
Shenzhen Yixiu… · near

29
3D Lighting… · lowest

7

What this shows Neurohabilitation's Innovation Score is 28.5/100 (28th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Neurohabilitation?

Each dot is one of Neurohabilitation’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neurohabilitation’s own 14.8 claims/patent is ABOVE the 9.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Neurohabilitation vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neurohabilitation's grants concentrate

Neurohabilitation Corporation is a focused PatentsView assignee: 5 CPC subclasses with 44.8% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2016 (21 grants) versus a trough of 1 in 2015. By volume, Neurohabilitation sits between Nsk-warner K.K. and Northern Tool & Equipment Company, Inc..

Nsk-warner K K

29
National Yunlin U…

29
Natural Extractio…

29
Natural Gas Solut…

29
Nextinput

29
Nihon Parkerizing

29
Ningbo Fotile Kit…

29
Northern Tool & E…

29
Neurohabilitation ◀

29

What this shows Neurohabilitation holds 29 patents at rank #10,705, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Neurohabilitation

By rank, the assignees closest to #10,705 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Neurohabilitation's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Neurohabilitation, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Neurohabilitation ranks #276 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (29 here).

Shenzhen Yixiu Technology Co., Ltd 29 Millennial Media LLC 29 SK hynix system ic Inc. 29 Kankakee Spikeball, Inc. 29

Neurohabilitation's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 28th percentile higher than 28% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Neurohabilitation Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.4%
2016	21	72.4%
2017	5	17.2%
2018	2	6.9%

Which technologies does Neurohabilitation Corporation patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 13

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 2

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 2

Y10T - Technical Subjects Covered BY Former US Classification 1

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Neurohabilitation Corporation's patent record in context - here's where to go next.

Neurohabilitation Corporation's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 44.8% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #10,703 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Neurohabilitation Corporation against Nsk-warner K.K., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.